HESH launches AI+ gene technology to empower comprehensive diabetes management

The Shenyang Clinical Medical Research Center for Diabetic Eye Disease, initiated by HESH, was recently inaugurated at the Innovative Forum on the Combined Treatment of Diabetic Eye Disease held in Shenyang. The center focuses on the development of new technologies for prevention, diagnosis, and treatment of diabetes-related eye diseases, as well as the establishment of diagnostic and treatment standards and efficacy evaluation research. Research directions include artificial intelligence and chronic disease management systems, genetic testing, and genetics. The center's expert group brings together multidisciplinary experts in internal medicine, ophthalmology, genetic technology, and AI smart healthcare, aiming to be clinically demand-oriented and patient-centered, promoting the transformation of innovative research results and enhancing the technical level of eye disease diagnosis and treatment